Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Glenn Schulman - Senior Vice President, Investor Relations Peter Greenleaf - President and Chief Executive Officer Neil Solomons - Chief Medical Officer Max Colao - Chief Commercial Officer Joe Miller - Chief Financial Officer Conference Call Participants Ken Cacciatore - Cowen & Company Maury Raycroft - Jefferies Justin Kim - Oppenheimer David Martin - Bloom Burton Ed Arce - H.C. Wa ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2020 Results Earnings Conference Call August 11, 2020 4:30 PM ET Company Participants Glenn Schulman - SVP, Corporate Communications and IR Peter Greenleaf - CEO and Director Neil Solomons - Chief Medical Officer Max Colao - Chief Commercial Officer Joe Miller - Chief Financial Officer Michael Martin - Chief Operating Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Ed Arce - H.C. Wainwright Joseph Schwartz - SVB Leerink Justin Kim - Oppenh ...

Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) Q1 2020 Earnings Conference Call May 14, 2020 4:30 PM ET Company Participants Glenn Schulman - SVP, Corporate Communications & IR Peter Greenleaf - President, CEO & Director Neil Solomons - Chief Medical Officer Max Colao - Chief Commercial Officer Joseph Miller - CFO Michael Martin - Co-Founder & COO Conference Call Participants Alethia Young - Cantor Fitzgerald & Co. Kenneth Cacciatore - Cowen and Company Joseph Schwartz - SVB Leerink Justin Kim - Oppenheimer An ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2019 Earnings Conference Call March 5, 2020 4:30 PM ET Company Participants Glenn Schulman – Head-Investor Relations Peter Greenleaf – President and Chief Executive Officer Dennis Bourgeault – Chief Financial Officer Neil Solomons – Chief Medical Officer Max Colao – Chief Commercial Officer Conference Call Participants Alethia Young – Cantor Fitzgerald Justin Kim – Oppenheimer & Company Ed Arce – HC Wainwright Joseph Schwartz – SVB Leerink David Martin – Bloom B ...

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2019 Earnings Conference Call November 14, 2019 4:30 PM ET Company Participants Glenn Schulman - Investor Relations Peter Greenleaf - Chief Executive Officer Dennis Bourgeault - Chief Financial Officer Neil Solomons - Chief Medical Officer Michael Martin - Chief Operating Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Joseph Schwartz - SVP Leerink Ed Arce - H.C. Wainwright Justin Kim - Oppenheimer & Company Operator Greetings, and welcome ...